Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone + NAC for DNS in CO Poisoning
NCT06811675Phase 4Recruiting
- Sponsor
- China Medical University Hospital
- Start
- Mar 2025
- Primary completion
- Jun 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in carbon monoxide poisoning comparing Dexamethasone + NAC with Placebo (2 arms). Primary endpoint: Incidence of Delayed Neurological Sequelae at 3 months. Started Mar 2025; status: recruiting.
02
Drugs
dexamethasoneacetylcysteine
03
Conditions
carbon monoxide poisoning
Beyond the preview
Go deeper on NCT06811675.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06811675.